Towards an integrated cellular and molecular: Definition of breast cancers;Les cancers du sein: Vers un modèle cellulaire et moléculaire intégré

Medecine/Sciences

Volumn 23, Issue 6-7, 2007, Pages 626-632

  Charafe Jauffret, Emmanuelle ^a   Chaffanet, Max ^a   Bertucci, François ^a   Ginestier, Christophe ^a   Jacquemier, Jocelyne ^a   DeLapeyrière, Odile ^a   Birnbaum, Daniel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HERMES ANTIGEN; LAPATINIB; TAMOXIFEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TRASTUZUMAB;

BREAST CANCER; BREAST CARCINOGENESIS; CELL DIFFERENTIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MOLECULAR GENETICS; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

EID: 34547107071     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20072367626     Document Type: Review

References (46)

1. Asselin-Labat ML, Sutherland KD, Barker H, et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 2006 ; 9 : 201-9.
2. Asselin-Labat ML, Shackleton M, Stingl J, et al. Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst 2006 ; 98 : 1011-4.
3. Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 2006 ; 127 : 1041-55.
4. Bertucci F, Houlgatte R, Benziane A, et al. Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet 2000 ; 9 : 2981-991.
5. Jenssen TK, Kuo WP, Stokke T, Hovig E. Associations between gene expressions in breast cancer and patient survival. Hum Genet 2002 ; 111 : 411-20.
6. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003 ; 100 : 8418-23.
7. Birnbaum D, Bertucci F, Ginestier C, Tagett R, et al. Basal and luminal breast cancers : basic or luminous ? Int J Oncol 2004 ; 25 : 249-58.
8. Charafe-Jauffret E, Ginestier C, Monville F, et al. How to best classify breast cancer : conventional and novel classifications. Int J Oncol 2005 ; 27 : 1307-13.
9. Neve RM, Chin K, Fridlyand J, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006 ; 10 : 515-27.
10. Charafe-Jauffret E, Ginestier C, Monville F, et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 2006 ; 25 : 2273-84.
11. Bertucci F, Borie N, Ginestier C, et al. Identification and validation of an ERBB2 gene expression signature in breast cancers. Oncogene 2004 ; 23 : 2564-75.
12. Konecny GE, Pegram MD, Venkatesan N, et al. Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells. Cancer Res 2006 ; 66 : 1630-9.
13. Abd El-Rehim DM, Ball G, Pinder SE, et al. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 2005 ; 116 : 340-50.
14. Dolled-Filhart M, Ryden L, Cregger M, et al. Classification of breast cancer using genetic algorithms and tissue microarrays. Clin Cancer Res 2006 ; 12 : 6459-68.
15. Jacquemier J, Ginestier C, Rougemont J, et al. Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Res 2005 ; 65 : 767-79.
16. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004 ; 10 : 5367-74.
17. Bertucci F, Finetti P, Rougemont J, et al. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res 2005 ; 65 : 2170-8.
18. Van Laere SJ, Van den Eynden GG, Van der Auwera I, et al. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Res Treat 2006 ; 95 : 243-55.
19. Bertucci F, Finetti P, Cervera N, et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res 2006 ; 66 : 4636-44.
20. Turner NC, Reis-Filho JS. Basal-like breast cancer and the BRCA1 phenotype. Oncogene 2006 ; 25 : 5846-53.
21. Korkola JE, DeVries S, Fridlyand J, et al. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res 2003 ; 63 : 7167-75.
22. Zhao H, Langerod A, Ji Y, et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 2004 ; 15 : 2523-36.
23. Buttitta F, Felicioni L, Barassi F, et al. PIK3CA mutation and histological type in breast carcinoma : high frequency of mutations in lobular carcinoma. J Pathol 2006 ; 208 : 350-5.
24. Holst F, Stahl PR, Ruiz C, et al. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet 2007 ; 39 : 655-60.
25. Chin K, DeVries S, Fridlyand J, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006 ; 10 : 529-41.
26. Gelsi-Boyer V, Orsetti B, Cervera N, et al. Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res 2005 ; 3 : 655-67.
27. Ray ME, Yang ZQ, Albertson D, et al. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res 2004 ; 64 : 40-7.
28. Reis-Filho JS, Simpson PT, Turner NC, et al. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin Cancer Res 2006 ; 12 : 6652-62.
29. Letessier A, Sircoulomb F, Ginestier C, et al. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers. BMC Cancer 2006 ; 6 : 245.
30. Coe BP, Ylstra B, Carvalho B, et al. Resolving the resolution of array CGH. Genomics 2007 ; 89 : 647-53.
31. Edgren H, Kallioniemi O. Integrated breast cancer genomics. Cancer Cell 2006 ; 10 : 453-4.
32. Sorlie T. Molecular classification of breast tumors : toward improved diagnostics and treatments. Meth Mol Biol 2007 ; 360 : 91-114.
33. Benvenuti S, Arena S, Bardelli A. Identification of cancer genes by mutational profiling of tumor genomes. FEBS Lett 2005 ; 579 : 1884-90.
34. Chanock SM, Burdett LP, Yeager MP, et al. Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas. Breast Cancer Res 2007 ; 9 : R5.
35. Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006 ; 314 : 268-74.
36. Moyano JV, Evans JR, Chen F, et al. AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest 2006 ; 116 : 261-70.
37. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004 ; 101 : 781-6.
38. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003 ; 17 : 1253-70.
39. Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005 ; 65 : 5506-11.
40. Al Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003 ; 100 : 3983-8.
41. Liu R, Wang X, Chen GY, et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007 ; 356 : 217-26.
42. Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002 ; 2 ; 367-76.
43. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea: a paradigm shift. Cancer Res 2006 ; 66 : 1883-90.
44. Carroll JS, Brown M. Estrogen receptor target gene: on evolving concept. Mol Endocrinol 2006 ; 20 : 1707-14.
45. Bergamaschi A, Kim YH, Wang P, et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chrom Cancer 2006 ; 45 : 1033-40.
46. Yao J, Weremowicz S, Feng B, et al. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res 2006 ; 66 : 4065-78.